The director-level sale of $14.36M is large in absolute terms and lacks a 10b5-1 plan, which typically signals a bearish view from the most informed insider. Monitor for any subsequent 8-K filings or earnings pre-announcements that could explain the timing.
Price Chart
Executive Summary
Two Teva insiders sold a combined $14.53M in shares on September 18, 2026. Director Roberto Mignone accounted for the vast majority ($14.36M), while Interim Chief Legal Officer Brian Savage sold $174K. The sales are open-market (code S) with no disclosed 10b5-1 plan, representing approximately 0.2% of Teva's market cap — a modest but notable insider selling event.
Key Financial Metrics
Key Facts
- Director Roberto Mignone sold 367,600 shares at $39.06 for $14.36M on September 18, 2026
- Interim Chief Legal Officer Brian Savage sold 4,500 shares at $38.69 for $174K on September 18, 2026
- Total insider sales of $14.53M represent approximately 0.2% of Teva's market cap
- No 10b5-1 plan indicated for either sale
- Both sales occurred on the same day, suggesting a coordinated window
Financial Impact
$14.53M in insider sales, ~0.2% of market cap
Risk Factors
- Director sale could signal negative non-public information about upcoming earnings or pipeline developments
- Concentration of sales on a single day suggests a deliberate decision, not routine diversification
- Teva's generic drug pricing environment and litigation overhang remain key risks
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TEVA-1790144421831 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Institutional Cluster | $41.11 | awaiting T+60 | — | $39.41 (+4.14%) |
Oct 8, 2026 18d ago | 3 | $41.10 | awaiting T+60 | — | $39.41 (−4.11%) |
Oct 2, 2026 24d ago | Press Release | $39.53 | awaiting T+60 | — | $39.41 (−0.30%) |
Oct 2, 2026 24d ago | Press Release | $39.53 | awaiting T+60 | — | $39.41 (−0.30%) |
Sep 30, 2026 26d ago | Press Release | $39.31 | awaiting T+60 | — | $39.41 (+0.25%) |
Sep 28, 2026 28d ago | Press Release | $39.81 | awaiting T+60 | — | $39.41 (−1.00%) |
Sep 23, 2026 4w ago | Press Release | $40.22 | awaiting T+60 | — | $39.41 (−2.01%) |
Sep 23, 2026 4w ago | Press Release | $40.22 | awaiting T+60 | — | $39.41 (−2.01%) |
Sep 22, 2026 4w ago | Insider Cluster | $39.01 | awaiting T+60 | — | $39.41 (−1.03%) |
Sep 18, 2026 5w ago | Press Release | $40.05 | awaiting T+60 | — | $39.41 (−1.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers